• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
    • Why Should You Support SAGES?
    • SAGES Swag
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Annual Meeting
      • 2027 Scientific Session Call for Abstracts
      • 2027 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Lead Up Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • Innovative Surgical Trends
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Advanced Laparoscopy and Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
    • Foregut Video Atlas
  • Opportunities
    • Join the SAGES Patient Partner Network (PPN)
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs
  • Learning Hub
You are here: Home / Abstracts / Laparoscopic Hepatectomy Results in Decreased Vegf Expression in Residual Hepatoma Cells When Compared to Open Resection

Laparoscopic Hepatectomy Results in Decreased Vegf Expression in Residual Hepatoma Cells When Compared to Open Resection

INTRODUCTION: Vascular endothelial growth factor (VEGF) is upregulated in hepatocellular carcinoma (HCC), and its level of expression in these tumors has been shown to impact tumor growth. We hypothesized that when compared to open liver resection, laparoscopic hepatectomy would result in decreased local angiogenic response in residual tumor cells.
MATERIALS AND METHODS: Right and left lobe hepatomas were induced in Buffalo rats via laparoscopic guided subcapsular injection of Morris hepatoma cells. One week later, animals were randomized to laparoscopic (LR=15) or open (OR=15) left medial hepatic lobectomy. Fourteen days after resection, the rats were sacrificed, the residual right lobe tumors were measured, and tissue was procured for RNA extraction. VEGF mRNA transcript levels were quantified with RT-PCR. VEGF serum levels were measured by ELISA prior to resection and at the time of tissue harvest.
RESULTS: None of the animals developed satellite liver lesions or distant metastases in the abdomen or thorax. Median residual tumor volume was 320mm3 in the open group, compared to 180mm3 in the laparoscopic group (p=0.164). Animals that underwent open resection had a 1.3 fold increase in VEGF mRNA transcript levels compared to the laparoscopic resection group (p=0.008). Serum VEGF levels were not significantly different between the laparoscopic and open groups at baseline (OR 23.7±12.0 pg/ml, LR 30.7±15.5 pg/ml, p=0.334) nor at the time of tissue harvest (OR 19.9±19.6, LR 26.9±34.5, p=0.549).
CONCLUSIONS: Laparoscopic hepatic resection resulted in decreased VEGF mRNA expression in residual hepatoma cells compared to open resection. Through inhibition of angiogenesis promoters in the tumor microenvironment, minimally invasive liver resection may contribute to a lower residual disease burden and ultimately lead to a lower recurrence rate.


Session: Podium Presentation

Program Number: S098

Related



Hours & Info

15821 Ventura Blvd Ste 400
Encino, CA 91436

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2026 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

Refine Search